N-butylscopolammonium reduces gastrointestinal peristalsis and rectal pressure via its anti-cholinergic actions by competitively inhibiting muscarinic receptors on smooth muscle. N-butylscopolammonium has shorter duration of action than atropine.
Because neomycin is more nephrotoxic and less effective against several bacterial species than either gentamicin or amikacin, its use is generally limited to topical formulations for skin, eyes, and ears, oral treatment of enteric infections, to reduce microbe numbers in the colon prior to colon surgery, and oral or enema administration to reduce ammonia-producing bacteria in the treatment of hepatic encephalopathy. Doses for parenteral administration are listed below, but should be used only with extreme caution due to the drug’s toxic potential.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
由獸醫師確認動物種類、年齡、診斷與是否可能需要急診或手術評估 由獸醫師核對實際產品、單方或複方、濃度、核准地區與食用動物狀態 由獸醫師確認心臟、腸胃阻塞、青光眼、排尿、繁殖狀態及全部併用藥風險 由獸醫師個別決定用法並安排治療後監測與復評 未完成上述契約時不得啟用計算、處方、飼主數字指示或自動交互作用
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。